Received a "Study May Proceed” letter from the FDA to evaluate amezalpat in combination with atezolizumab (TECENTRIQ®) and ...
HOUSTON, March 27, 2025 (GLOBE NEWSWIRE) -- KULR Technology Group, Inc. (NYSE American: KULR) (the "Company" or "KULR"), a ...
This week, a federal judge dismissed a lawsuit brought against the U.S. government and an internet watchdog organization.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback